Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2018

Aug 14, 2018

BUY
$99.64 - $127.59 $139,496 - $178,626
1,400 New
1,400 $220,000
Q1 2018

May 15, 2018

SELL
$105.8 - $150.94 $222,180 - $316,974
-2,100 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$81.25 - $130.7 $170,625 - $274,470
2,100
2,100 $374,000

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $24.7M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.